Genomtec has signed up a new Partner for the commercialization of its flagship Genomtec® ID genetic testing platform and the Respiratory Panel 5-Plex test.
The Partner is appointed by Genomtec S.A. to help with identification and qualification of new local business prospects and opportunities for the Genomtec® ID platform. The company will assist in selecting partners for obtaining market authorization in Taiwan and facilitating access to the Taiwanese market with Genomtec products.
The Partner is an innovative Polish – Taiwanese – Japanese biotechnology company specializing in the “go-to-market strategy” for medical diagnostics and nutraceuticals, specifically in the East Asian market. Their achievements are renowned internationally via many accolades and based on a close cooperation with the well-established Japanese and Taiwanese suppliers and experts in the biotechnology segment.
“We are thrilled for this opportunity to expand in Taiwan through this partnership. Our Partner will be invaluable in both enhancing our ability to source and qualify potential business partners willing to enter into commercial agreements pertaining to sales and distribution of our products in Taiwan and representing the Genomtec brand in the local industry meetings, trade fairs, conferences. Being able to introduce such a rapid portable point-of-care diagnostics technology in the Taiwanese market is in line with our expansion strategy and we are excited to welcome our Partner onboard” said Charudutt Shah, Chief Business Officer at Genomtec S.A.
On June 8, 2022, Genomtec S.A. announced obtaining the CE-IVD mark for its flagship solution, the Genomtec® ID Respiratory Panel 5-Plex (RP5-PLEX). It is the only diagnostic panel of its kind currently available in the European Union that simultaneously examines presence of the most relevant pathogens causing respiratory tract infections in the same test. The Genomtec® ID RP5-PLEX panel detects Influenza A/ B viruses, RSV (Respiratory Syncytial Virus), SARS-CoV-2, and bacteria causing atypical pneumoniae, i.e., Mycoplasma pneumoniae and Chlamydophila pneumoniae. The Genomtec® ID Analyzer that orchestrates genetic analysis of loaded patient’s sample onto the microfluidic reaction card (RP5-PLEX panel), is one of the smallest portable POCT genetic testing devices in the world.
